0.2101
Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
53.94%
32.56
|
21.15 | 25.20 | 26.51 | 41.75 |
| Operating Income/Loss |
53.94%
-32.56
|
-21.15 | -25.20 | -26.51 | -41.75 |
| Nonoperating Income/Loss |
139.32%
-0.162
|
0.412 | 0.061 | 0.062 | 0.80 |
| Net Income/Loss |
57.78%
-32.72
|
-20.74 | -25.14 | -26.45 | -40.95 |
| Basic Average Shares |
14.29%
72.25
|
63.22 | - | 60.57 | 60.57 |
| Diluted Average Shares |
14.29%
72.25
|
63.22 | - | 60.57 | 60.57 |
| Basic Earnings Per Share |
36.36%
-0.45
|
-0.33 | - | -0.44 | -0.68 |
| Diluted Earnings Per Share |
36.36%
-0.45
|
-0.33 | - | -0.44 | -0.68 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):